| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sight Sciences, Inc. (SGHT) has 9 insiders with recent SEC Form 4 filings, including 9 buys and 7 sells. SGHT is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 6.03M | $31.58M | - | |
| Other | 1.91M | $10.02M | - | |
| 10% | 1.39M | $7.29M | - | |
| Other | 832.3K | $4.36M | - | |
| COO | 600.0K | $3.14M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 2025 | Bauerlein Alison73 | Chief Financial Officer | Sell | 19,948 | $3.30 | $65,828.40 | -3.2% | +139.6% | - | |
| Oct 1, 2025 | Badawi Paul62 | President And CEO | Sell | 24,441 | $3.34 | $81,632.94 | -0.4% | +138.8% | - | |
| Jul 3, 2025 | Hayden Jeremy B.63 | Chief Legal Officer | Sell | 9,160 | $4.17 | $38,233.84 | -3.3% | -20.4% | - | |
| Jul 3, 2025 | Badawi David59 | Chief Technology Officer | Sell | 5,679 | $4.17 | $23,704.15 | -0.3% | -20.4% | - | |
| Jul 2, 2025 | Bauerlein Alison73 | Chief Financial Officer | Sell | 19,260 | $4.10 | $78,927.48 | -3.0% | -17.3% | - | |
| Jul 2, 2025 | Link Matthew66 | Chief Commercial Officer | Sell | 4,889 | $4.10 | $20,035.12 | -0.6% | -17.3% | - | |
| Jul 1, 2025 | Badawi Paul62 | President And CEO | Sell | 23,637 | $4.15 | $98,140.82 | -0.4% | -14.5% | - | |
| Jun 6, 2025 | Encrantz Staffan74 | Director, 10% Owner | Buy | 90,525 | $4.22 | $381,957.97 | +2.3% | -11.2% | - | |
| Jun 3, 2025 | Encrantz Staffan74 | Director, 10% Owner | Buy | 98,782 | $3.81 | $376,429.44 | +2.8% | -3.7% | +12.9% | |
| May 29, 2025 | Encrantz Staffan74 | Director, 10% Owner | Buy | 128,189 | $3.52 | $451,734.06 | +4.0% | +20.2% | +38.1% |